Literature DB >> 19567748

Cardiac calsequestrin: quest inside the SR.

Sandor Györke1, Sarah C W Stevens, Dmitry Terentyev.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19567748      PMCID： PMC2727018          DOI： 10.1113/jphysiol.2009.172049

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  23 in total

1.  Luminal Ca2+ controls termination and refractory behavior of Ca2+-induced Ca2+ release in cardiac myocytes.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Héctor H Valdivia; Ariel L Escobar; Sandor Györke
Journal:  Circ Res       Date:  2002-09-06       Impact factor: 17.367

2.  Comparing skeletal and cardiac calsequestrin structures and their calcium binding: a proposed mechanism for coupled calcium binding and protein polymerization.

Authors:  HaJeung Park; Il Yeong Park; EunJung Kim; Buhyun Youn; Kelly Fields; A Keith Dunker; ChulHee Kang
Journal:  J Biol Chem       Date:  2004-02-10       Impact factor: 5.157

Review 3.  Deconstructing calsequestrin. Complex buffering in the calcium store of skeletal muscle.

Authors:  Leandro Royer; Eduardo Ríos
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

4.  Oligomerisation of Ca2+-regulatory membrane components involved in the excitation-contraction-relaxation cycle during postnatal development of rabbit skeletal muscle.

Authors:  G R Froemming; K Ohlendieck
Journal:  Biochim Biophys Acta       Date:  1998-09-08

5.  Use of chlorotetracycline fluorescence to demonstrate Ca2+-induced release of Ca2+ from the sarcoplasmic reticulum of skinned cardiac cells.

Authors:  A Fabiato; F Fabiato
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

6.  Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Alex V Postma; Isabelle Denjoy; Theo M Hoorntje; Jean-Marc Lupoglazoff; Antoine Da Costa; Pascale Sebillon; Marcel M A M Mannens; Arthur A M Wilde; Pascale Guicheney
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

Review 7.  A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia.

Authors:  Michael Eldar; Elon Pras; Hadas Lahat
Journal:  Trends Cardiovasc Med       Date:  2003-05       Impact factor: 6.677

8.  Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model.

Authors:  Nicoletta Rizzi; Nian Liu; Carlo Napolitano; Alessandra Nori; Federica Turcato; Barbara Colombi; Silvio Bicciato; Diego Arcelli; Alessandro Spedito; Mario Scelsi; Laura Villani; Giovanni Esposito; Simona Boncompagni; Feliciano Protasi; Pompeo Volpe; Silvia G Priori
Journal:  Circ Res       Date:  2008-06-26       Impact factor: 17.367

9.  Junctin and calsequestrin overexpression in cardiac muscle: the role of junctin and the synthetic and delivery pathways for the two proteins.

Authors:  Pierre Tijskens; Larry R Jones; Clara Franzini-Armstrong
Journal:  J Mol Cell Cardiol       Date:  2003-08       Impact factor: 5.000

10.  Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Inna Györke; Pompeo Volpe; Simon C Williams; Sandor Györke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-16       Impact factor: 11.205
View more
  30 in total

Review 1.  Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes.

Authors:  David H MacLennan; S R Wayne Chen
Journal:  J Physiol       Date:  2009-07-01       Impact factor: 5.182

2.  Calsequestrin, triadin and more: the molecules that modulate calcium release in cardiac and skeletal muscle.

Authors:  Eduardo Ríos; Sandor Györke
Journal:  J Physiol       Date:  2009-07-01       Impact factor: 5.182

Review 3.  Calcium signaling in cardiac myocytes.

Authors:  Claire J Fearnley; H Llewelyn Roderick; Martin D Bootman
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

Review 4.  Calcium signalling in developing cardiomyocytes: implications for model systems and disease.

Authors:  William E Louch; Jussi T Koivumäki; Pasi Tavi
Journal:  J Physiol       Date:  2015-02-09       Impact factor: 5.182

5.  Calsequestrin depolymerizes when calcium is depleted in the sarcoplasmic reticulum of working muscle.

Authors:  Carlo Manno; Lourdes C Figueroa; Dirk Gillespie; Robert Fitts; ChulHee Kang; Clara Franzini-Armstrong; Eduardo Rios
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

Review 6.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

7.  Quantification of calsequestrin 2 (CSQ2) in sheep cardiac muscle and Ca2+-binding protein changes in CSQ2 knockout mice.

Authors:  Robyn M Murphy; Janelle P Mollica; Nicole A Beard; Bjorn C Knollmann; Graham D Lamb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-03       Impact factor: 4.733

8.  High-capacity Ca2+ binding of human skeletal calsequestrin.

Authors:  Emiliano J Sanchez; Kevin M Lewis; Benjamin R Danna; Chulhee Kang
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

Review 9.  Ryanodine receptors: structure, expression, molecular details, and function in calcium release.

Authors:  Johanna T Lanner; Dimitra K Georgiou; Aditya D Joshi; Susan L Hamilton
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-20       Impact factor: 10.005

10.  Accelerated junctional rhythm and nonalternans repolarization lability precede ventricular tachycardia in Casq2-/- mice.

Authors:  Ure L Mezu; Prabhpreet Singh; Vladimir Shusterman; Hyun-Seok Hwang; Bjorn C Knollmann; Jan Němec
Journal:  J Cardiovasc Electrophysiol       Date:  2012-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.